In the area of popular awareness, there is often a misunderstanding that anti-bacterial drugs and prophylactic bacteria cannot be used simultaneously. This perception has led many people to face treatment for the disease, either with serious concerns about their combined use, or to errors in their use due to a lack of correct guidance, which affects treatment effectiveness and health recovery.
Antibacterial drugs, the main effect of which is to contain or kill pathogenic bacteria that cause human infections, thus enabling the body to overcome disease. In terms of the mechanism of action, it prevents bacteria from normal growth and reproduction, ultimately for the purpose of controlling the infection, by interfering with critical physiological processes such as cytowall synthesis, protein synthesis or nucleic acid metabolism of bacteria. For example, common penicillin-type drugs can inhibit the synthesis of bacterial cell walls and cause bacteria to break up under osmosis pressure, while headgillin-likes produce antibacterial activity for a variety of gelatin positive and vaginal bacteria in a similar way.
Benobacteria, a class of active micro-organisms that are beneficial to human health, are common in amphibian, acidic and lactose. They are mainly found in the intestines of the human body and perform a number of important functions. On the one hand, prophylactic bacteria can participate in the digestive process of food, helping humans to decompositate difficult-to-absorbed substances, such as dietary fibres, to transform them into nutrients that can be absorbed into humans; on the other hand, they can competitively inhibit the implantation and growth of harmful bacteria in the intestinal mucous membranes, build biological barriers to the intestinal tract, enhance the immune function of the intestinal tract, promote intestinal creeping and maintain the balance and stability of intestinal microecologicals.
The reason why antibacterials and biobacteria are not used at the same time is mainly the fear that antibacterials will be eliminated in conjunction with the fungi, thus preventing it from performing its beneficial effects. However, that is not entirely the case. While it is true that antibacterial drugs have some impact on the prophylactic bacteria, both can work together through reasonable choice and use strategies.
In the selection of prophylactic bacteria, relatively insensitive strains of antibacterial drugs can be selected. There are differences in the sensitivity of different prophylactic strains to antibacterial drugs. For example, the Brasil yeast is naturally resistant to most commonly used antibacterial drugs, and the combination of the Brasil yeast formulation during treatment with antibacterial drugs can maintain to some extent the microecological balance of the intestinal tract and reduce the incidence of adverse intestinal strains caused by the use of antibacterial drugs, such as diarrhoea and abdominal swelling.
Adjusting the time interval for use is also a key strategy. The use of antibacterial drugs is generally recommended for 2 – 3 hours. The aim is to minimize the opportunity for direct contact between antibacterial drugs and the fungi within the gastrointestinal tract. When antibacterials function over time, their concentrations in the gastrointestinal tract are reduced, and the effect on subsequent ingestion of the fungi is correspondingly reduced, so that the fungi is better positioned and effective in the intestine.
For special cases, such as severe intestinal infections requiring long-term treatment with antibacterial drugs, doctors may also introduce a phased replanting programme, depending on the patient ‘ s specific circumstances. Increased doses and time of use of prophylactic bacteria, i.e., during intermittent periods of antibacterial treatment or after completion of the treatment process, will help the intestinal population to return to normal as soon as possible.
In medical practice, there have been many successful cases in which the rational combination of antibacterial drugs and prophylactic bacteria can achieve good therapeutic results. In the field of paediatrics, in cases of combined gastrointestinal disorders in children ‘ s respiratory tracts, the use of antibacterial drugs to control respiratory infections is accompanied by the timely supplementation of fungi, which is both effective in treating infections and in alleviating intestinal problems caused by antibacterials, such as diarrhoea and appetite disorders, and promotes the rehabilitation of infected children.
Antibacterial drugs and prophylactic bacteria are not immune. As long as we follow a scientific approach, we make a rational choice of the strain of the fungi, manage the time interval for its use and develop individualized use programmes on a case-by-case basis, both can work together to preserve the micro-ecological balance of the intestinal system while treating the disease and to protect our health. People at large should reject misconceptions and use antibacterial drugs and probacterials properly, under the professional guidance of doctors, in order to achieve better health benefits.
